Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

We investigated the relationships between glucocorticoid use, disease activity, and changes in body mass index (BMI) in patients with antineutrophil cytoplasmic antibody–associated vasculitis (AAV).

[1]  P. van Paassen,et al.  Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis. , 2015, Journal of the American Society of Nephrology : JASN.

[2]  R. Zhong,et al.  Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis , 2015, Arthritis Research & Therapy.

[3]  A. Laviano,et al.  Cachexia: clinical features when inflammation drives malnutrition , 2015, Proceedings of the Nutrition Society.

[4]  A. Nakamura.  Genotypes of the renin–angiotensin system and glucocorticoid complications , 2015, Pediatrics international : official journal of the Japan Pediatric Society.

[5]  L. Alfredsson,et al.  Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis , 2014, Annals of the rheumatic diseases.

[6]  P. Merkel,et al.  Efficacy of remission-induction regimens for ANCA-associated vasculitis. , 2013, The New England journal of medicine.

[7]  D. Gladman,et al.  Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis , 2013, Annals of the rheumatic diseases.

[8]  J. Jacobs,et al.  Increase of body mass index in a tight controlled methotrexate‐based strategy with prednisone in early rheumatoid arthritis: Side effect of the prednisone or better control of disease activity? , 2013, Arthritis care & research.

[9]  P. Merkel,et al.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis. , 2010, The New England journal of medicine.

[10]  P. Merkel,et al.  Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index , 2010, Annals of the rheumatic diseases.

[11]  C. Ferro,et al.  Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study. , 2009, Arthritis and rheumatism.

[12]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, Lancet.

[13]  P. Merkel,et al.  Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis. , 2008, Arthritis and rheumatism.

[14]  Hyon K. Choi,et al.  Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. , 2007, Archives of internal medicine.

[15]  Jeffrey R Curtis,et al.  Population-based assessment of adverse events associated with long-term glucocorticoid use. , 2006, Arthritis and rheumatism.

[16]  M Cutolo,et al.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data , 2005, Annals of the rheumatic diseases.

[17]  P. Merkel,et al.  Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). , 2005, Arthritis and rheumatism.

[18]  T. MacDonald,et al.  Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease , 2004, Annals of Internal Medicine.

[19]  Ralph B D'Agostino,et al.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.

[20]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[21]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[22]  B. Thiers.  Obesity, Waist Circumference, Weight Change, and the Risk of Psoriasis in Women: Nurses' Health Study II , 2008 .

[23]  Who Consultation on Obesity.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.